Real-world comparison of androgen receptor pathway ınhibitors versus docetaxel as first-line treatment in metastatic hormone-sensitive prostate cancer

Current Medical Research and Opinion · Published 2026-04-03 · DOI 10.1080/03007995.2026.2682050

Authors being retrieved — see the publisher record. https://doi.org/10.1080/03007995.2026.2682050

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Promising results amid persistent disparities in real-world adherence to multitarget stool DNA testing · Current Medical Research and Opinion · 2026 · Same journal
Original Abstracts from the 22nd Annual Meeting of ISMPP · Current Medical Research and Opinion · 2026 · Same journal
Quantifying US healthcare provider preferences for the treatment of post-transplant cytomegalovirus infection using a discrete choice experiment · Current Medical Research and Opinion · 2026 · Same journal
Serum calcium and liver injury in people living with HIV: a longitudinal cohort study in Southeast China · Current Medical Research and Opinion · 2026 · Same journal
A novel hypothesis for stroke prediction, introducing CHA 2 DS 2 -VAScF · Current Medical Research and Opinion · 2026 · Same journal
Seizing the opportune moment: early use of antiplatelet therapy for thrombolysis · Current Medical Research and Opinion · 2026 · Same journal
Tirzepatide compared with semaglutide in obesity disease: a subpopulation analysis applying Japan Society for the Study of Obesity criteria in the global SURMOUNT-5 trial · Current Medical Research and Opinion · 2026 · Same journal
Original Abstracts from the 2026 European Meeting of ISMPP · Current Medical Research and Opinion · 2026 · Same journal
Adverse effect profile of amphotericin B deoxycholate administered with a standardized infusion protocol in hematologic patients: a prospective study in a resource-limited setting · Current Medical Research and Opinion · 2026 · Same journal
Percutaneous electrocoagulation (PAPS-PEC) for incompetent perforator veins: a cost-effective technical innovation for venous ulcer healing · Current Medical Research and Opinion · 2026 · Same journal